Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06928337 · ClinicalTrials.gov registry record
Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.
A clinical trial of Fertility Disorders, sponsored by Fairtility.
- Recruiting
- Registry status
- 350
- Enrollment target
- 1
- Study location
NCT06928337 is a study of Fertility Disorders that is actively recruiting participants, run by Fairtility. The registered enrollment target is 350 participants, below the 1,478-participant average among 3 other Fertility Disorders trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06928337, a study of Fertility Disorders, is actively recruiting participants, sponsored by Fairtility.
- RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.
Conditions Studied
Interventions
- DEVICE AI evaluation of oocytes.
Study Locations (1)
Arizona
- The World Egg and Sperm Bank - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06928337
The ClinicalTrials.gov registry entry for NCT06928337 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,478-participant average among 3 other Fertility Disorders trials with a reported enrollment target (76% lower). The listed sponsor is Fairtility, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fertility Disorders appearing as the primary indexed condition, and to 1 intervention - of which AI evaluation of oocytes. is the first listed.
NCT06928337 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06928337 about?
NCT06928337 is a clinical study titled "Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.". This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be condu...
What is the current status of trial NCT06928337?
This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2025-05-01. Estimated completion is 2026-05-01.
What conditions does trial NCT06928337 study?
This clinical trial studies the following conditions: Fertility Disorders.
What interventions are being tested in trial NCT06928337?
The interventions under investigation include: AI evaluation of oocytes. (DEVICE).
Who is sponsoring clinical trial NCT06928337?
This trial is sponsored by Fairtility, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06928337 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fertility Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.